2013 Physician Quality Reporting System Data Collection Form: Hepatitis C (For patients aged 18 and over)
|
|
- Elwin Ford
- 7 years ago
- Views:
Transcription
1 2013 Physician Quality Reporting System Data Collection Form: (For patients aged 18 and over) Physician Name: Patient Name: Last First MI Gender: Patient Insured - M F Traditional Medicare*: Medicare Advantage: Other: Date of Birth: / / mm dd yyyy Medical Record Number: App t Date: / / mm dd yyyy ICD-9 : Encounter: *Note: A minimum of 11 patients must be Traditional Medicare Part B Patient sample criteria for the Measures Group are patients aged 18 years and older with a specific diagnosis of chronic hepatitis C accompanied by a specific patient encounter: The following diagnosis code indicating chronic hepatitis C: Accompanied by one of the following patient encounter codes: 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, The appointment date must be between Jan 1 through Dec 31, Each measure needs to have been assessed at least once during the 12 m reporting period. If more than one assessment; record the most recent information. PLEASE REFER TO THE HEPATITIS C USER GUIDE FOR FURTHER INFORMATION
2 Patient Name: Page 2 of 5 Physician Quality Reporting Measure # 84 : : Ribonucleic Acid (RNA) Testing Before Initiating Treatment treatment for whom quantitative HCV RNA testing was performed within 6 months prior to initiation of antiviral treatment RNA testing performed within 6 months RNA testing not performed within 6 months for medical reason Document reason(s) in medical chart (e.g if patient is first seen by physician after initiation of treatment) RNA testing not performed within 6 months, reason unspecified Patient not Receiving Antiviral Treatment for Physician Quality Reporting Measure # 85 : : HCV Genotype Testing Prior to Treatment genotype testing documented as performed prior to initiation of antiviral treatment for genotype testing performed prior to the initiation of antiviral treatment Genotype testing not performed, reason unspecified Patient not receiving antiviral treatment for
3 Patient Name: Page 3 of 5 Physician Quality Reporting Measure # 86 : : Antiviral Treatment Prescribed diagnosis of chronic hepatitis C who were prescribed at a minimum peginterferon and ribavirin therapy within the 12-month reporting period Prescribed May include prescription given to the patient for at a minimum peginterferon and ribavirin therapy at one or more visits in the 12-month period OR patient already taking at a minimum peginterferon and ribavirin therapy as documented in current medication list (i.e., may include additional antiviral therapy, as appropriate). therapy prescribed therapy not prescribed for- therapy not prescribed, reason unspecified System Reason Physician Quality Reporting Measure # 87 : : HCV Ribonucleic Acid (RNA) Testing at Week 12 of Treatment treatment for whom quantitative HCV RNA testing was performed at no greater than 12 weeks from the initiation of antiviral treatment Quantitative RNA Testing at 12 weeks treatment for Quantitative RNA Testing not performed at 12 weeks for treatment for documented Quantitative RNA Testing not performed at 12 weeks, reason unspecified treatment for documented Patient not Receiving Antiviral Treatment for
4 Patient Name: Page 4 of 5 Physician Quality Reporting Measure # 89 : : Counseling Regarding Risk of Alcohol Consumption diagnosis of hepatitis C who were counseled about the risks of alcohol use at least once within 12-months Patient counseled about risks of alcohol use Patient counseled about risks of alcohol use not performed, reason not specified Counseling May include documentation of a discussion regarding the risks of alcohol, or notation to decrease or abstain from alcohol intake. Physician Quality Reporting Measure # 90 : : Counseling Regarding Use of Contraception Prior to Antiviral Therapy Percentage of female patients aged 18 through 44 years and all men aged 18 years and older with a treatment who were counseled regarding contraception prior to the initiation of treatment Counseling regarding contraception received prior to initiation of antiviral treatment Counseling regarding contraception not received for medical reason Counseling regarding contraception not Not Eligible patient is Female and older than age 44 Patient not receiving antiviral treatment for
5 Patient Name: Page 5 of 5 Physician Quality Reporting Measure # 183 : : Hepatitis A Vaccination in Patients with HCV diagnosis of hepatitis C who received at least one injection of hepatitis A vaccine, or who have documented immunity to hepatitis A administered or previously received Patient has documented immunity to Hepatitis A received for Physician Quality Reporting Measure # 184 : : Hepatitis B Vaccination in Patients with HCV diagnosis of hepatitis C who received at least one injection of hepatitis B vaccine, or who have documented immunity to hepatitis B administered or previously received Patient has documented immunity to Hepatitis B received for
2016 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older)
2016 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older) IMPTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered satisfactory
More informationPhysician Quality Reporting System (PQRS)
Physician Quality Reporting System (PQRS) and the Value-Based Payment Modifier Implementation guide for registry-based reporting for the Hepatitis C (HCV) Measures Group 2015 1 Overview of PQRS 1,2 What
More information2015 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older)
2015 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered
More informationHepatitis C Virus Direct-Acting Antivirals Prior Authorization Request Form
Hepatitis C Virus Direct-Acting Antivirals Prior Authorization Request Form For assistance, please call 1-855-552-6028 or fax completed form to 570-271-5610. Medical documentation may be requested. This
More informationMEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. I. Requirements for Prior Authorization of Hepatitis C Agents
MEDICAL ASSISTANCE HBOOK I. Requirements for Prior Authorization of Hepatitis C Agents A. Prescriptions That Require Prior Authorization Prescriptions for Pegasys and non-preferred Hepatitis C Agents must
More informationMEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. I. Requirements for Prior Authorization of Hepatitis C Agents
MEDICAL ASSISTANCE HBOOK PRI AUTHIZATION OF PHARMACEUTICAL SERVICES I. Requirements for Prior Authorization of Hepatitis C Agents A. Prescriptions That Require Prior Authorization Prescriptions for Interferon,
More informationHEPATITIS C THERAPY PRIOR AUTHORIZATION FORM: Page 1 of 3 Patient Information. Diagnosis Acute Hep C Chronic Hep C Hepatocellular Carcinoma
HEPATITIS C THERAPY PRIOR AUTHORIZATION FORM: Page 1 of 3 Patient Information Recipient: MA#: Date of Birth: Phone #: Body Weight: Treatment Plan Sovaldi (sofosbuvir) 400mg: Take once daily for weeks Olysio
More informationMEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. I. Requirements for Prior Authorization of Hepatitis C Agents
MEDICAL ASSISTANCE HBOOK I. Requirements for Prior Authorization of Hepatitis C Agents A. Prescriptions That Require Prior Authorization Prescriptions for Hepatitis C Agents that meet any of the following
More informationHCSP GUIDES A GUIDE TO: PREPARING FOR TREATMENT. A publication of the Hepatitis C Support Project
HCSP GUIDES T R E AT M E N T I S S U E S A publication of the Hepatitis C Support Project The information in this guide is designed to help you understand and manage HCV and is not intended as medical
More informationHepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs
Last update: February 23, 2015 Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs Please see healthpartners.com for Medicare coverage criteria. Table of Contents 1. Harvoni 2. Sovaldi
More informationHepatitis C. David Mutimer Queen Elizabeth Hospital Liver Unit Birmingham. Substance Misuse Treatment in the West Midlands. How can we reduce harm?
Hepatitis C David Mutimer Queen Elizabeth Hospital Liver Unit Birmingham Substance Misuse Treatment in the West Midlands. How can we reduce harm? Birmingham October 19 th 2007 infection HCV Natural History
More informationJanuary 2014 Physician Quality Reporting System (PQRS): What s New for 2014 Purpose Important Changes for 2014 PQRS PQRS Incentive Individual EPs
January 2014 Physician Quality Reporting System (PQRS): What s New for 2014 Purpose This fact sheet includes important information about changes to the Physician Quality Reporting System (PQRS) for 2014.
More informationPreface. TTY: (888) 232-6348 or cdcinfo@cdc.gov. Hepatitis C Counseling and Testing, contact: 800-CDC-INFO (800-232-4636)
Preface The purpose of this CDC Hepatitis C Counseling and Testing manual is to provide guidance for hepatitis C counseling and testing of individuals born during 1945 1965. The guide was used in draft
More information2016 Physician Quality Reporting System Data Collection Form: General Surgery (for patients aged 18 and older)
2016 Physician Quality Reporting System Data Collection Form: General Surgery (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered
More informationClinical Criteria for Hepatitis C (HCV) Therapy
Diagnosis Clinical Criteria for Hepatitis C (HCV) Therapy Must have chronic hepatitis C (HCV infection > 6 months), genotype and sub-genotype specified to determine the length of therapy; Liver biopsy
More informationINFLAMMATORY BOWEL DISEASE (IBD) MEASURES GROUP OVERVIEW
SPECIFICATION F MEASURES GROUP REPTING ONLY INFLAMMATY BOWEL DISEASE (IBD) MEASURES GROUP OVERVIEW 2012 PHYSICIAN QUALITY REPTING OPTIONS F MEASURES GROUPS: REGISTRY ONLY 2012 PHYSICIAN QUALITY REPTING
More information3/25/2014. April 3, 2014. Dennison MM, et al. Ann Intern Med. 2014;160:293 300.
April 3, 2014 3.6 million persons ever infected; 2.7 million chronic infections 1 Up to 75% unaware of status Transmitted through percutaneous exposure to infected blood Injection drug use (IDU) is the
More informationCommonly Asked Questions About Chronic Hepatitis C
Commonly Asked Questions About Chronic Hepatitis C From the American College of Gastroenterology 1. How common is the hepatitis C virus? The hepatitis C virus is the most common cause of chronic viral
More informationSchool Based Health Care Coding at Your Best
School Based Health Care Coding at Your Best Presented by Carley Spangler, CPC Account Manager, OCHIN Billing Services October 2011 OCHIN 707 SW Washington Suite 1200 Portland, OR 97205 P 503-943-2500
More informationSovaldi (sofosbuvir) Prior Authorization Criteria
INITIAL REVIEW CRITERIA Sovaldi (sofosbuvir) Prior Authorization Criteria 1. Adult patient age 18 years old; AND 2. Prescribed by a hepatologist, gastroenterologist, infectious disease specialist, transplant
More informationPrior Authorization Policy
Prior Authorization Policy http://www.paramounthealthcare.com/providers Ribavirin Rebetol (ribavirin capsule or oral solution) Copegus (ribavirin tablet), Moderiba (ribavirin tablet), Ribasphere (ribavirin
More informationClinical Criteria for Hepatitis C (HCV) Therapy
Diagnosis Clinical Criteria for Hepatitis C (HCV) Therapy Must have chronic hepatitis C, genotype and sub-genotype specified to determine the length of therapy; Liver biopsy or other accepted test demonstrating
More informationKlamath Tribal Health & Family Services 3949 South 6 th Street Klamath Falls, OR 97603
Klamath Tribal Health & Family Services 3949 South 6 th Street Klamath Falls, OR 97603 Phone: (541) 882-1487 or 1-800-552-6290 HR Fax: (541) 273-4564 OPEN: 10/02/12 CLOSE: WHEN FILLED POSITION: RESPONSIBLE
More informationPRIOR AUTHORIZATION POLICY
PRIOR AUTHORIZATION POLICY Harvoni (sofosbuvir/ledipasvir tablets Gilead) To initiate a Coverage Review, Call 1-800-417-1764 OVERVIEW Harvoni is a fixed-dose combination of ledipasvir, a hepatitis C virus
More informationWHEREAS updates are required to the Compensation Plan for Pharmacy Services;
M.O. 23/2014 WHEREAS the Minister of Health is authorized pursuant to section 16 of the Regional Health Authorities Act to provide or arrange for the provision of health services in any area of Alberta
More informationMEDICAL POLICY STATEMENT
MEDICAL POLICY STATEMENT Original Effective Date Next Annual Review Date Last Review / Revision Date 5/21/2014 3/24/2016 3/24/2015 Policy Name Policy Number Hepatitis C Oral SRx-0003 Medical Policy Statements
More informationPRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT
PRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT HARVONI (90mg ledipasvir/400mg sofosbuvir): tablet (PREFERRED AGENT) SOVALDI (sofosbuvir ): 400mg tablets (PREFERRED AGENT ) OLYSIO (simeprivir) PEG-INTRON
More informationCoding and Billing. Commonly Asked Questions. Physician Office Reimbursement Guideline Q1. A1. Q2. A2.
Coding and Billing oorasure Technologies is pleased to provide you information on billing and reimbursement for HCV testing with the OraQuick HCV Rapid Antibody Test. Correctly identifying services delivered
More informationSUPPORT PATH PROGRAM INTAKE FORM PHONE: 1-855-769-7284 FAX: 1-855-298-8700
SUPPORT PATH PROGRAM INTAKE FORM PHONE: 1-855-769-7284 FAX: 1-855-298-8700 1 REQUESTED SERVICE(S) (REQUIRED) CHECK ALL BOXES THAT APPLY Benefits Investigation Prior Authorization and Appeals Support Patient
More informationWhat GI Practices Need to Know About the Electronic Health Record Incentive Program. Joel V. Brill, MD, AGAF Lawrence R. Kosinski, MD, MBA, AGAF
What GI Practices Need to Know About the Electronic Health Record Incentive Program Joel V. Brill, MD, AGAF Lawrence R. Kosinski, MD, MBA, AGAF Disclosures Joel V. Brill, MD AGAF AGA Registry Executive
More informationHepatitis C Treatment Expansion Initiative Multi-Site Conference Call. March 16, 2011
Hepatitis C Treatment Expansion Initiative Multi-Site Conference Call March 16, 2011 Case Presentations Kansas City Free Health Clinic Carilion Clinic Didactic Session Challenges in Determining HCV Treatment
More informationPhysician Quality Reporting System (PQRS)
Physician Quality Reporting System (PQRS) and the Value-Based Payment Modifier 2015 1 Implementation guide for registry-based reporting for the Inflammatory Bowel Disease (IBD) Measures Group Overview
More informationUnderstanding Your Role in Maximizing Revenue in a FQHC
Understanding Your Role in Maximizing Revenue in a FQHC Cynthia M Patterson President N Charleston SC 29420-1093 Firstchoice.practicesolutions@gmail.com P: (843) 597-8437 F: (888) 697-8923 Have systems
More informationNYC Health Department Surveillance Study: Barriers to Hep C Treatment Among NYC Residents
NYC Health Department Surveillance Study: Barriers to Hep C Treatment Among NYC Residents Andrea V. King, MPH New York City Department of Health and Mental Hygiene GOALS OF OUR STUDY To describe clinical
More informationNew Substance Abuse Screening and Intervention Benefit Covered by BadgerCare Plus and Medicaid
Update December 2009 No. 2009-96 Affected Programs: BadgerCare Plus, Medicaid To: All Providers, HMOs and Other Managed Care Programs New Substance Abuse Screening and Intervention Benefit Covered by BadgerCare
More informationCompensation Plan for Pharmacy Services
Compensation Plan for Pharmacy Services Attachment A Section 1 - Definitions ABC Pharmacy Agreement means an agreement between ABC and a Community Pharmacy as described in Schedule 2.1 of the Alberta Blue
More informationHUSKY Health Benefits and Prior Authorization Requirements Grid* Medical Equipment, Device and Supplies (MEDS) Effective: January 1, 2012
Contraceptives Effective 7/1/13: Condoms and spermicide will be covered when dispensed by MEDS providers Not covered Effective 7/1/13: Condoms and spermicide will be covered when dispensed by MEDS providers
More informationHIV Pre-Exposure Prophylaxis (PrEP): A brief guide for providers updated January 2016
HIV Pre-Exposure Prophylaxis (PrEP): A brief guide for providers updated January 2016 Daily emtricitabine/tenofovir (Truvada ) is safe and effective for reducing the risk of HIV acquisition in sexually
More informationMost Frequently Asked Questions about Applied Behavior Analysis Services for the Treatment of Children under 21 with Autism Spectrum Disorders
Most Frequently Asked Questions about Applied Behavior Analysis Services for the Treatment of Children under 21 with Autism Spectrum Disorders Common Abbreviations ABA Applied Behavior Analysis AHCA The
More informationPresented by. Terri Gonzalez Director of Practice Improvement North Carolina Medical Society
Presented by Terri Gonzalez Director of Practice Improvement North Carolina Medical Society Meaningful Use is using certified EHR technology to: Improve quality, safety, efficiency, and reduce errors Engage
More informationWhen an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII)
XI. OCCUPATIONAL EXPOSURES TO HEPATITIS B AND C RECOMMENDATION: When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII) The risk of transmission
More informationTreating Chronic Hepatitis C. A Review of the Research for Adults
Treating Chronic Hepatitis C A Review of the Research for Adults Is This Information Right for Me? Yes, this information is right for you if: Your doctor* has told you that you have chronic hepatitis C.
More informationHBV DNA < monitoring interferon Rx
Hepatitis B Virus Suspected acute hepatitis >>Order: Acute Unknown hepatitis screen Suspected chronic hepatitis >>Order: Chronic unknown hepatitis screen Acute HBV or Delayed Anti HBs response after acute
More informationVIII. Dentist Crosswalk
Page 27 VIII. Dentist Crosswalk Overview The final rule on meaningful use requires that an Eligible Professional (EP) report on both clinical quality measures and functional objectives and measures. While
More informationA pharmacist s guide to Pharmacy Services compensation
Alberta Blue Cross Pharmaceutical Services A pharmacist s guide to Pharmacy Services compensation 83443 (2015/12) GENERAL DESCRIPTION... 3 Details... 3 ASSESSMENT CRITERIA... 3 Assessment for a Prescription
More informationOffice ID Location: City State Date / / PRIMARY CARE SURVEY
A. Organizational Characteristics PRIMARY CARE SURVEY We want to learn more about the general features of your office. A1. What health-related services does your office provide (check all that apply)?
More informationHepatitis C Glossary of Terms
Acute Hepatitis C A short-term illness that usually occurs within the first six months after someone is exposed to the hepatitis C virus (HCV). 1 Antibodies Proteins produced as part of the body s immune
More informationOphthalmology Meaningful Use Attestation Guide Stage 1 2013 Edition
Ophthalmology Meaningful Use Attestation Guide Stage 1 2013 Edition Ophthalmologists can register for the Medicare electronic health record (EHR) incentive program on the CMS website: https://ehrincentives.cms.gov
More informationPCMH Quality Metrics Report Deadline: March 31, 2015 Guidance Packet
PCMH Quality Metrics eport Deadline: March 31, 2015 Guidance Packet Monica J. Lindeen Commissioner of Securities & Insurance Montana State Auditor 840 Helena Ave. Helena, MT 59601 Phone: 406.444.2040 or
More informationViral Hepatitis Case Report
Page 1 of 9 Viral Hepatitis Case Report Perinatal Hepatitis B Virus Infection Michigan Department of Community Health Communicable Disease Division Investigation Information Investigation ID Onset Date
More informationAppropriate Treatment for Children with Upper Respiratory Infection
BCBS ACO Measure Appropriate Treatment for Children with Upper Respiratory Infection HEDIS Measure CPT II coding required: YES Click here to go to Table of Contents BCBS Measure: Page 50 of 234 Dated:
More informationNew IDSA/AASLD Guidelines for Hepatitis C
NORTHWEST AIDS EDUCATION AND TRAINING CENTER New IDSA/AASLD Guidelines for Hepatitis C John Scott, MD, MSc Associate Professor, UW SoM Asst Director, Liver Clinic, Harborview Medical Center Presentation
More informationPREVENTIVE HEALTHCARE GUIDELINES INTRODUCTION
PREVENTIVE HEALTHCARE GUIDELINES INTRODUCTION Health Plan of Nevada and Sierra Health and Life suggest that health plan members get certain screening tests, exams and shots to stay healthy. This document
More informationPrescription Drug Plan
Prescription Drug Plan The prescription drug plan helps you pay for prescribed medications using either a retail pharmacy or the mail order program. For More Information Administrative details and procedures
More informationCirrhosis and HCV. Jonathan Israel M.D.
Cirrhosis and HCV Jonathan Israel M.D. Outline Relationship of fibrosis and cirrhosisprevalence and epidemiology. Sequelae of cirrhosis Diagnosis of cirrhosis Effect of cirrhosis on efficacy of treatment
More informationSchedule of Benefits for the MoDOT/MSHP Medical Plan Medicare ASO PPO 20088 Effective 1/1/2016
Schedule of Benefits for the MoDOT/MSHP Medical Plan Medicare ASO PPO 20088 Effective 1/1/2016 This Schedule of Benefits summarizes your obligation towards the cost of certain covered services. Refer to
More informationUnderstanding Hepatitis C Treatment Access
Understanding Hepatitis C Treatment Access Robert Greenwald, JD, Clinical Professor of Law & Director, Center for Health Law and Policy Innovation of Harvard Law School May 2015 Comments Based on Findings
More informationInitial Preventive Physical Examination
Initial Preventive Physical Examination Overview The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 expanded Medicare's coverage of preventive services. Central to the Centers
More informationSession 4 Treatment Challenges
Session 4 Treatment Challenges Patient Management Programs Lead to Improved Adherence for Patients with Hepatitis C using Drug Dual Therapy in both Retail and Central Pharmacies Authors: Francis C. Staskon,
More informationEHR Demo Scenarios - Pediatrics. Female child 18 months old, here with mother for well child exam, including immunizations.
1. Well child scenario with complication Female child 18 months old, here with mother for well child exam, including immunizations. The patient s mother tells the front desk that there is a court order
More informationHepatitis C Virus (HCV)
HFS Report to Legislative Task Force Hepatitis C Arvind Goyal MD, MPH, MBA Medical Director Illinois Department of Healthcare and Family Services Hepatitis C Virus (HCV) Slowly progressive disease 40 years-median
More informationConsumer Guide to. Health Insurance. Oregon Insurance Division
Consumer Guide to Health Insurance Oregon Insurance Division The Department of Consumer and Business Services, Oregon s largest business regulatory and consumer protection agency, produced this guide.
More informationDisclosure. C.R. Sullivan, MD 1. Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu. The West Virginia Model
West Virginia University School of Medicine BEHAVIORAL MEDICINE & PSYCHIATRY Morgantown, WV Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu Disclosure Reckitt Benckiser
More informationPreventive Health Services
understanding Preventive Health Services For the most current version of this document, visit www.wellwithbluemt.com or www.bcbsmt.com. Preventive health services include evidence-based screenings, immunizations,
More informationHCV in 2020: Any cases left? Rafael Esteban Hospital General Universitario Valle Hebron Barcelona. Spain
HCV in 2020: Any cases left? Rafael Esteban Hospital General Universitario Valle Hebron Barcelona. Spain Yes, still too many Measures to eradicate an Infectious Disease Prevention: Vaccination Screening
More informationINSTRUCTIONS FOR REPORTING IMMUNIZATION SERVICES TO THIRD PARTY PAYERS (Billing Guide)
INSTRUCTIONS FOR REPORTING IMMUNIZATION SERVICES TO THIRD PARTY PAYERS (Billing Guide) NOTE: All italicized words or phrases are defined at the end of this document. Adults (19 years of age and older)
More informationNational Hepatitis C Database for infection acquired through blood and blood products
National Hepatitis C Database for infection acquired through blood and blood products for infection acquired through blood and blood products 2010 Report National Hepatitis C Database for infection acquired
More informationPQRS Claims Measures Details- Quick Reference 2014
Measure Preventive Care and Screening: Body Mass Index (BMI) Screening and #128 Follow-up Medicare patients 18+ years of age, screened for BMI Normal: Age 65 years and older BMI > 23 and < 30 Age 18 to
More informationMeaningful Use Objectives
Meaningful Use Objectives The purpose of the electronic health records (EHR) incentive program is not so much the adoption of health information technology (HIT), but rather how HIT can further the goals
More informationThere have been significant
Managing Clinical Quality Measures for Meaningful Use and PQRS Using the EHR Method These tips will make it easier to qualify. By Seth Flam, DO Charlieaja Dreamstime.com There have been significant changes
More informationHIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK
HIV and Hepatitis Co-infection Martin Fisher Brighton and Sussex University Hospitals, UK Useful References British HIV Association 2010 http://www.bhiva.org/documents/guidelines/hepbc/2010/ hiv_781.pdf
More informationBirth Date: Sex: Home Phone Number:
A 35674 To apply for AmeriHealth Medigap Plans... Please reference the enclosed AmeriHealth Medigap Plans Outline of Coverage for the monthly premium based on your plan. Check the ONE plan for which you
More informationLiver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider:
Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP Primary Care Provider: If you are considering hepatitis C treatment, please read this treatment
More informationIronwood Ridge High School Health Office. Terry Clark, BS, RN, NCSN Phone: 520.696.3939 Fax: 520.696.3999 tclark@amphi.com
Ironwood Ridge High School Health Office Terry Clark, BS, RN, NCSN Phone: 520.696.3939 Fax: 520.696.3999 tclark@amphi.com Nicole Harvey, Health Assistant Phone: 520.696.3937 nharvey@amphi.com Location:
More informationErnest Boyd, R.Ph., MBA Executive Director Ohio Pharmacists Association
Ernest Boyd, R.Ph., MBA Executive Director Ohio Pharmacists Association CDC s Guide for Pharmacist Partnership for Public Health Brief overview of Pharmacists All graduate with 6 to 8 year Doctor of Pharmacy
More informationThe following should be current within the past 6 months:
EVALUATION Baseline Labs Obtain at time or prior to initial evaluation CBC with diff PT/INR CMP HCV Genotype (obtained PRIOR TO consult visit) HCV RNA (obtained PRIOR TO consult visit) Hep A IgG Hep BsAg,
More informationAnnually for adults ages 55 80 years with 30 pack/year smoking history and currently smoke or quit within the past 15 years Hepatitis B screening
Preventive Care Schedule Effective January 1, 2016 Highmark Blue Cross Blue Shield Express Scripts The plan pays for preventive care only when given by a network provider. Certain vaccines are available
More informationDemonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology
Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology The chart below lists the measures (and specialty exclusions) that eligible providers must demonstrate
More information[TRANSITIONS ] Short Term Recovery Care Application TRS-336-XX [ER/ASSOC#: ] Applicant Name (First, MI, Last) Social Security Number Email Address
I. APPLICANT INFORMATION: 1. IDENTIFYING INFORMATION: [TRANSITIONS ] Short Term Recovery Care Application TRS-336-XX [ER/ASSOC#: ] [Administrative Offices:] [165 Court Street] [Rochester, NY 14647] [1-800-544-0327]
More informationMeaningful Use Reporting Quick Reference
Allscripts Professional EHR 9.2 none Copyright 2010 Allscripts Healthcare Solutions, Inc. www.allscripts.com Copyright 2010 Allscripts Healthcare Solutions, Inc. This document is the confidential property
More informationUpdate on Hepatitis C. Sally Williams MD
Update on Hepatitis C Sally Williams MD Hep C is Everywhere! Hepatitis C Magnitude of the Infection Probably 8 to 10 million people in the U.S. are infected with Hep C 30,000 new cases are diagnosed annually;
More informationIntroduction 70. Who can sponsor under the family class? 70. Who can be sponsored in the family class? 70. Can I sponsor if I live outside Canada?
Introduction 70 Who can sponsor under the family class? 70 Who can be sponsored in the family class? 70 Can I sponsor if I live outside Canada? 72 Do I have to financially support the person/s I sponsor?
More informationPediatric and Adolescent Medical Record Review Tool
Pediatric and Adolescent Medical Record Review Tool Primary Care Provider: Member Name: DOB: Provider Name: Provider ID #: Product: Date of Review: Initials of Reviewer: The Medical Record contains the
More informationFREQUENTLY ASKED QUESTIONS ABOUT THE CVS CAREMARK PRESCRIPTION DRUG PROGRAM
FREQUENTLY ASKED QUESTIONS ABOUT THE CVS CAREMARK PRESCRIPTION DRUG PROGRAM ABBVIE EMPLOYEES WANT TO KNOW What s New in 2015? AbbVie is making changes in its pharmacy benefit program to ensure our medical
More informationAdministrative Code. Title 23: Medicaid Part 224 Immunizations
Administrative Code Title 23: Medicaid Part 224 Immunizations Table of Contents Title 23: Division of Medicaid... 1 Part 224: Immunizations... 1 Part 224 Chapter 1: General... 1 Rule 1.1: Reserved... 1
More informationReview: How to work up your patient with Hepatitis C
Review: How to work up your patient with Hepatitis C You screened your patient, and now the HCV antibody test is positive. What do you do next? The antibody test only means they have been exposed to HCV.
More information2016 HEDIS & Quality Assurance Reporting Requirements Measures Provider Reference Guide
2016 HEDIS & Quality Assurance Reporting Requirements Measures Provider Reference Guide HEDIS Measure: Test/Care Needed for Compliance Adult BMI Assessment Individuals ages 18-74 Documentation of BMI and
More informationReporting Audiology Quality Measures: A Step-by-Step Guide
What is PQRS? The Physician Quality Reporting System (PQRS) is a program through the Centers for Medicare and Medicaid Services (CMS) designed to improve the quality of care to Medicare beneficiaries by
More informationNEW DRUGS FOR THE TREATMENT OF HEPATITIS C. Marcella Honkonen, PharmD, BCPS AzPA Annual Convention. Sunday, June 29 th, 2014 (1:15-2:15)
NEW DRUGS FOR THE TREATMENT OF HEPATITIS C Marcella Honkonen, PharmD, BCPS AzPA Annual Convention. Sunday, June 29 th, 2014 (1:15-2:15) Objectives Determine initial treatment options for patients with
More informationAccountable Care Project EMR Reporting Guide January 6, 2014
Accountable Care Project EMR Reporting Guide January 6, 2014 Web Reporting System The system can be accessed at http://www.nhaccountablecare.org. You will need the ID and password assigned to you by NHIHPP
More informationInstructions to Complete Ancillary Service Authorization Request For Physical Therapy, Speech Therapy, Occupational Therapy
Western Oregon Advanced Health, LLC. P.O. Box 1096 Coos Bay, OR 97420 Instructions to Complete Ancillary Service Authorization Request For Physical Therapy, Speech Therapy, Occupational Therapy Provider
More informationRoutine Preventive Services. Covered by Medicare 2012
Routine Preventive Services Covered by Medicare 2012 Brook Golshan, CPC, ACS-EM 2/20/2012 1 Preventive Services Covered by Medicare 2012 Covered by Medicare Part B: Original/Direct Medicare Most of the
More informationWomen have a different relationship to the health care system than
CHAPTER 4: WOMEN S ACCESS TO HEALTH CARE have a different relationship to the health care system than men. are more likely to use health care services because of their health status, higher incidence of
More informationPREPARED BY THE CENTER FOR HEALTH LAW AND POLICY INNOVATION OF HARVARD LAW SCHOOL
Pennsylvania PREPARED BY THE CENTER FOR HEALTH LAW AND POLICY INNOVATION OF HARVARD LAW SCHOOL Pennsylvania Hepatitis C Virus (HCV) in Pennsylvania Prevalence + + Although state-wide data were unavailable,
More informationPOLICY HIGH BRIDGE BOARD OF EDUCATION. Pupils 5530/Page 1 of 6 SUBSTANCE ABUSE 5530 SUBSTANCE ABUSE
5530/Page 1 of 6 5530 M The Board of Education recognizes that a pupil s abuse of harmful substances seriously impedes that pupil s education and threatens the welfare of the entire school community. The
More informationManitoba EMR Data Extract Specifications
MANITOBA HEALTH Manitoba Data Specifications Version 1 Updated: August 14, 2013 1 Introduction The purpose of this document 1 is to describe the data to be included in the Manitoba Data, including the
More information2013 Meaningful Use Dashboard Calculation Guide
2013 Meaningful Use Dashboard Calculation Guide Learn how to use Practice Fusion s Meaningful Use Dashboard to help you achieve Meaningful Use. For more information, visit the Meaningful Use Center. General
More informationBeginner's guide to Hepatitis C testing and immunisation against hepatitis A+B in general practice
Beginner's guide to Hepatitis C testing and immunisation against hepatitis A+B in general practice Dr Chris Ford GP & SMMGP Clinical Lead Kate Halliday Telford & Wrekin Shared Care Coordinator Aims Discuss:
More informationAttribute appropriate and inappropriate services to provider of initial visit
Optimal Care for Acute Low Back Pain - Adults Primary Care Description The rate represents the percentage of members ages 18 and older with newly diagnosed acute low back pain who received optimal care
More informationCompleting and Submitting Request for Homebound Instruction Packet
Request for Homebound Instruction Important Information for Parent/Guardian Home/Hospital and Transition Supports Purpose of Homebound Instruction. The purpose of homebound instruction is to provide educational
More information